BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11771566)

  • 21. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis in capsular warning syndrome.
    Vivanco-Hidalgo RM; Rodriguez-Campello A; Ois A; Cucurella G; Pont-Sunyer C; Gomis M; Cuadrado-Godia E; Roquer J
    Cerebrovasc Dis; 2008; 25(5):508-10. PubMed ID: 18477844
    [No Abstract]   [Full Text] [Related]  

  • 24. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).
    Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Garami Z; Barreto A; Spengos K; Forteza A; Mikulik R; Sharma VK; Brunser A; Martinez P; Montaner J; Kohrmann M; Schellinger PD; Alexandrov AV;
    Int J Stroke; 2008 Feb; 3(1):66-72. PubMed ID: 18705918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era.
    Chalela JA; Kang DW; Luby M; Ezzeddine M; Latour LL; Todd JW; Dunn B; Warach S
    Ann Neurol; 2004 Jan; 55(1):105-12. PubMed ID: 14705118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate indications for administration of tPA.
    Dachs R
    Am Fam Physician; 2005 Aug; 72(3):381; author reply 381-2. PubMed ID: 16100851
    [No Abstract]   [Full Text] [Related]  

  • 27. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guidelines for the general management of patients with acute ischemic stroke].
    Chang YJ; Ryu SJ; Chen JR; Hu HH; Yip PK; Chiu TF;
    Acta Neurol Taiwan; 2008 Dec; 17(4):275-94. PubMed ID: 19280874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program.
    LaBresh KA; Reeves MJ; Frankel MR; Albright D; Schwamm LH
    Arch Intern Med; 2008 Feb; 168(4):411-7. PubMed ID: 18299497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statement outlines prevention measures for ischemic stroke.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Feb; 12(3):7-9. PubMed ID: 11767793
    [No Abstract]   [Full Text] [Related]  

  • 31. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emergency department: first line of defense in preventing secondary stroke.
    Ovbiagele B
    Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cutting-edge of medicine; new concept of TIA and changes in management of acute ischemic stroke].
    Minematsu K
    Nihon Naika Gakkai Zasshi; 2013 Mar; 102(3):731-7. PubMed ID: 23777168
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke telepresence: removing all geographic barriers.
    Hess DC; Switzer JA
    Neurology; 2011 Mar; 76(13):1121-3. PubMed ID: 21368282
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue plasminogen activator for transient ischemic attack: the case for "off-label" use of thrombolytics.
    Sobel RM; Wu DT; Hester K; Anda K
    Am J Emerg Med; 2014 Mar; 32(3):277-9. PubMed ID: 24377761
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment--Transient cerebral ischemia demands urgent evaluation.
    Graham CA
    Stroke; 2003 Oct; 34(10):2451-2. PubMed ID: 14500925
    [No Abstract]   [Full Text] [Related]  

  • 38. Tennessee, Ohio health care organizations dramatically improve stroke diagnosis and treatment.
    Rep Med Guidel Outcomes Res; 2000 May; 11(10):10, 12. PubMed ID: 11770549
    [No Abstract]   [Full Text] [Related]  

  • 39. What is NICE about the latest stroke guidelines for general practitioners?
    Gibson JC
    Qual Prim Care; 2009; 17(2):95-7. PubMed ID: 19416601
    [No Abstract]   [Full Text] [Related]  

  • 40. World Stroke Day 2016 - "Face the facts: Stroke is treatable".
    Davis S; Norrving B; Lalor E; Brainin M; Hacke W
    Int J Stroke; 2016 Oct; 11(8):844-845. PubMed ID: 28068889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.